CIK 0001766140 · <br>Emerging growth company
Unicycive Therapeutics, Inc.
Sign in to watch- Ticker
- UNCY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813638692
- Phone
- 650-384-0642
- Business address
- 1975 W. EL CAMINO REAL, SUITE 204, MOUNTAIN VIEW, CA, 94040
- Former names
- Unicycive Therapeutics, Inc.
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- CERT Other Certification
- 8-A12B Other Registration of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 14 of 16 · 307 filings